Authors: DAHAN R JAILLON P LEHNER JP CAZOR JL CLOARECBLANCHARD L DAHAN R DUCHIER J GUINOT P JAILLON P LEHNER JP LOEB F MACQUINMAVIER C PUECH A ROLAND E ROUVEIX B TEULEESPIE M THULLIEZ C VITOU P

Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301